Skip to content
Company Spotlight

Medpace Continues to Lead: Recognized with 2024 CRO Leadership Awards 

  • June 28, 2024

Medpace, a global, full-service clinical research organization (CRO), reaffirms its industry leadership by once again being recognized with CRO Leadership Awards presented by Life Science Leader and Clinical Leader. Medpace received five awards across all categories, including Capabilities, Compatibility, Expertise, Quality, and Reliability.

Medpace has a track record of recognition, having received CRO leadership awards in each the last 7 consecutive years. The company is focused on Making the Complex Seamless® for drug sponsors – with a unique, quality-focused operating model, high-caliber study teams that are consistent from project onset to closeout, and integrated services and technology to deliver operational excellence on a global scale.  

For the 2024 CRO Leadership Awards, Life Science Leader and Clinical Leader teamed up with Industry Standard Research (ISR) to determine award recipients. 42 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey to determine the CROs that meet or exceed their customers’ expectations in the categories of Capabilities, Compatibility, Expertise, Quality, and Reliability. Medpace was recognized as having exceeded its customers’ expectations across all five categories. Survey respondents were selected from biopharmaceutical companies of all sizes, vetted for CRO decision-making authority, and were asked to evaluate only companies they have worked on an outsourced project in the past 10 months to ensure the data behind the awards are driven by first-hand experience with the CROs being evaluated.  

Your Next Clinical Breakthrough Starts Here

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 42 countries.